Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

Blocking PD-1: Progress in HIV Cure Research

Blocking PD-1: Progress in HIV Cure Research

, by Liz Highleyman

Blocking a signaling molecule called PD-1 on immune cells is one way researchers are reducing HIV viral load and improving immune system function in monkeys. Find out what role this strategy might play in the search for an HIV cure. Read More

Timothy Ray Brown, the Berlin Patient, Accepts Award

Timothy Ray Brown, the Berlin Patient, Accepts Award

, by Liz Highleyman

The Berlin Patient recently accepted an award at a San Francisco HIV cure symposium. Find out why he receives special recognition as researchers use his case to learn more about how to cure HIV. Read More

CROI 2015: Hepatitis C—Both the Good News and Bad

CROI 2015: Hepatitis C—Both the Good News and Bad

, by Liz Highleyman

Recent drug advances bring a cure for hepatitis C to many. But delayed treatment, liver disease, and drug costs all give cause for concern. Read More

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

, by Liz Highleyman

What’s new in the world of HIV drug development? CROI brought us updates on a potentially safer version of tenofovir and a new type of drug that just established proof-of-concept. Read More

PrEP Open House: What to Know if You’re Interested in PrEP

PrEP Open House: What to Know if You’re Interested in PrEP

, by Liz Highleyman

San Franciscans recently heard from people with experience taking PrEP and learned where to get access. Read More